ZYXI News and Press, Zynex Inc. From 06/13/22

Zynex Announces Change of Auditor PR Newswire ENGLEWOOD, Colo. , June 13, 2022 /PRNewswire/ -- Zynex, Inc . ("Zynex or the "Company) (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medi...

Two new Breakout Stocks for Week 24 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +80.9% YTD. High frequency breakouts continue despite Negative Momentum Gauge® signals midweek with peak gains in 1 of 4 picks above 10%: L...

Zynex (ZYXI +0.8%) approved a program to buy back $10M of the company's common stock. The program will commence on June 10, 2022 and is scheduled to terminate on June 9, 2023 or when the $10M buyback limit is reached. Company expects to finance the purchases with existing cash balances, ...

Zynex Announces Additional Share Buyback Program PR Newswire ENGLEWOOD, Colo. , June 9, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

The spread of the “recession” meme is starting to reach a fever pitch (1). In this case, it could counterintuitively be a positive catalyst for the long duration side of the market – ie, the long-term growth bets that are still in their early innings, with big fireworks s...

I will offer some perspective about how bad today's market action was and what it may mean going forward. Of the 1,505 stocks in the S&P 1500 Composite index, only 78 were up today, while 1,422 were down and 5 were unchanged. There are now 1,010 stocks (67.1% of the index) tha...

Zynex Medical to Participate in Upcoming Investor Conferences PR Newswire ENGLEWOOD, Colo. , May 10, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasi...

Zynex Ranks 250 in Financial Times List of "The Americas' Fastest Growing Companies 2022" PR Newswire ENGLEWOOD, Colo. , May 3, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) , an innovative medical technology company specializing in the manufac...

Zynex, Inc. (ZYXI) Q1 2022 Earnings Conference Call April 28, 2022 4:15 PM ET Company Participants Louisa Smith – Investor Relations-Gilmartin Group Thomas Sandgaard – Chairman, President and Chief Executive Officer Anna Lucsok – Chief Operating Officer Don Gregg –...

Zynex press release (NASDAQ:ZYXI): Q1 GAAP EPS of $0.03 misses by $0.02. Revenue of $31.08M (+28.8% Y/Y) beats by $0.06M. Adjusted EBITDA increased 897% to $3.1 million Announced Share Buyback Program up to $10M over next 12 months. As of March 31, 2022, the Company had working capital of $59...